REPL vs WTW · $825.7M cap vs P/E 15, rev $9.93B
Replimune Group Inc (REPL) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
REPL does not have a complete income-statement cache yet.
Latest reported WTW revenue for 2024-12-31 was $9.93B. Net income was -$88.0M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
REPL currently screens at market cap $825.7M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the REPL and WTW stock pages for the full models.
Not investment advice.